phosphoenolpyruvate has been researched along with Glioblastoma in 2 studies
Phosphoenolpyruvate: A monocarboxylic acid anion derived from selective deprotonation of the carboxy group of phosphoenolpyruvic acid. It is a metabolic intermediate in GLYCOLYSIS; GLUCONEOGENESIS; and other pathways.
phosphoenolpyruvate : A monocarboxylic acid anion resuting from selective deprotonation of the carboxy group of phosphoenolpyruvic acid.
phosphoenolpyruvic acid : A monocarboxylic acid that is acrylic acid substituted by a phosphonooxy group at position 2. It is a metabolic intermediate in pathways like glycolysis and gluconeogenesis.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Weille, J | 1 |
| Fabre, C | 1 |
| Gaven, C | 1 |
| Bakalara, N | 1 |
| Chinnaiyan, P | 1 |
| Kensicki, E | 1 |
| Bloom, G | 1 |
| Prabhu, A | 1 |
| Sarcar, B | 1 |
| Kahali, S | 1 |
| Eschrich, S | 1 |
| Qu, X | 1 |
| Forsyth, P | 1 |
| Gillies, R | 1 |
2 other studies available for phosphoenolpyruvate and Glioblastoma
| Article | Year |
|---|---|
Similar pyruvate kinase modifications in glioblastoma cells by 7β-hydroxycholesterol and glutamine withdrawal.
Topics: AMP-Activated Protein Kinases; Animals; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Prolifer | 2013 |
The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism.
Topics: Gas Chromatography-Mass Spectrometry; Glioblastoma; Glioma; Humans; Mesoderm; Metabolomics; Neoplasm | 2012 |